Harmonization of the disintegration test between Chinese Pharmacopoeia and ICH Q4B Annex 5(R1)
1National Institutes for Food and Drug Control, Beijing 102629, China
2Guyuan City Inspection and Testing Center for Market Regulation, Guyuan 756000, China
3Chinese Pharmacopoeia Commission, Beijing 100061, China
4Tianjin Tianda Tianfa Technology Co., Ltd., Tianjin 300392, China
5Milestone Pharma, Nanjing 210061, China
6Shanghai Center of Drug Evaluation and Inspection, Shanghai 201210, China
7China Novartis Institutes for Biomedical Research Co., Ltd., Shanghai 201203, China
8Bristol-Myers Squibb (China) Investment Co., Ltd., Shanghai 200020, China
收起